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Purpose: A simple, reliable and rapid chemical identification system (RCIS) consisting of three colour 
reactions based on the functional  groups in  the molecule and two TLC methods was developed for 
preliminary detection of the 5–nitroimidazole  drugs.  
Methods: Three members of this group of drugs (tablet form) available in the Nigerian market and 
labelled MA and MB for metronidazole, T A and TB   for tinidazole and S for secnidazole, were used. The 
extraction of the active ingredient from the solid dosage form was performed using acetone. The 
reaction of the extracted drug with zinc and 1M hydrochloric acid at 100 
o
C  converted the nitroimidazole 
group to a characteristic primary aromatic amine. TLC methods A and B were carried out on GF254 
plates (5cm x 10cm) to further identify the individual members of the group. TLC method A with mobile 
phase consisting of acetone, ethyl acetate and ammonia (100:5:1) and method B with mobile phase 
consisting of acetone, chloroform and ammonia (100:15:1) were developed for the identification. 
Results: The aromatic character of 5-nitroimidazole was highlighted in nitric acid when combined with 
sulphuric acid resulting in an orange colour. 40% sodium hydroxide gave the alkali-induced 
characteristic orange colour of aromatic amino compounds. All the samples of the various brands gave 
characteristic colours that distinguished the compounds of the 5-nitroimidazole group as primary or 
secondary nitroimidazole compounds. 
Conclusion:  Using the developed method, fraudulently labelled product 5-nitroimidazole antiprotozoal 
and antibacterial agents can now be detected in approx. 40 min with limited reagents and a simple TLC 
technique. The method is rugged, simple, and should be particularly handy for use in detecting 
substandard products of the drug in the drug distribution chain where sophisticated equipment are often 
not available. 
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INTRODUCTION 
 
The world is confronted by the reality of 
large-scale counterfeit production of almost 
every conceivable drug [1,2].
 
It is not 
surprising then that drugs are produced in 
gross violation of good manufacturing 




therefore, desirable that deliberate and 
fraudulent labeling of drugs with respect to 
identity should be detected along the 
distribution chain as part of normal quality 
assurance processes [4]. There is the need 
to make available useful methods for 
accurately validating the authenticity and 
identity of available medications. This is in 
view of the fact that the greatest health risk 
faced by people of the world today is the lack 
of appropriate medicines for treating both 
common and life-threatening illnesses [4,5]. 
The dangers posed by counterfeit products to 
public health in Nigeria have resulted in 
control measures by the Agency for Food and 
Drug Administration and Control (NAFDAC) 
such as daily enlightenment campaigns in the 
media [6,7]. A way to complement NAFDAC’s 
efforts against counterfeit drugs is to develop 
a simple and rapid method of identifying fake 
products [8]. The growing challenge is halting 
the distribution and marketing of such 
medicines at every level of the distribution 
chain [9, 10].  
Equipment with multi-component profiling for 
the screening of chemicals have been 
documented in literature but their high cost 
often render unaffordable to several 
stakeholder along the distribution chain in 
several developing countries [11,12].
 
Furthermore, such equipment requires 
technical handling and maintenance that are 
beyond the capacity of those in the 
distribution chain [13]. A Fast Chemical 
Identification System (FCIS), as has been 
used in China since 2005, needs to be 
developed and compiled for the use of 
pharmacists and other stakeholders to 
include drugs such as anti-infective drugs, 
analgesics, cardiovascular agents, etc. FCIS 
is usually targeted at the molecular structure 
and functional groups in the drug molecule 
[14-16]. 
 
The 5-nitroimidazole compounds are widely 
used intestinal and extra-intestinal 
amoebicide. There has been documented 
evidence of the efficacy of the 5-
nitroimidazoles on the causative organism, 
Entamoeba histolytica [17]. The increase in 
cases of amoebiasis is said to be traceable to 
counterfeiting [18-20]. The 5-nitroimidazoles 
most commonly found in the Nigerian market 
are metronidazole, tinidazole and 









R Metronidazole  -CH2-CH2OH  
2-methyl-5 nitroimidazole-1-ethanol  
Tinidazole  -CH2SO2C2H5 
Ethyl [2-(2-methyl-5-nitro-1-imidazolyl)] ethyl 
sulphone  Secnidazole  -CH2-CH(OH)-CH3 
∝, 2-Dimethyl-5-nitro-1H-imidazole-1-ethanol 
 
Fig 1: Chemical structure of 5-nitroimidazole 






Branded products of metronidazole, 
tinidazole and secnidazole in tablet form were 
purchased from a registered pharmacy in 
Uyo, Nigeria. Free samples of these drugs 
were also obtained from May and Baker Plc 
and Cadila Pharmaceuticals Ltd, both in 
Lagos, Nigeria. Paracetamol tablets were 
similarly purchased while pure paracetamol 
powder was obtained free of charge from 
May and Baker Plc. Further details are shown 
in Table 1. Chloroform, acetone, methanol, 
ethyl acetate, bismuth  subnitrate,  
hydrochloric acid, sodium hydroxide, 
sulphuric acid, nitric acid, sodium nitrate were 
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bought from Nanjing Chemical Reagent 
Company, China, and were of analytical 
grade. TLC silica GF254 plates (5cm x 10cm) 
were cut from 20cm x 30cm plates (Acres 
Organics, Belgium).  
 
Preparation of test solution and crystals 
 
Tablets of each of the drugs were crushed in 
a mortar and reduced into fine powder, and 1 
g of the powder was shaken thoroughly in 
100 ml of acetone in a conical flask. The drug 
was extracted into acetone and filtered with a 
filter paper. The filtrate (50 ml) was allowed to 
stand at room temperature for 15min to 
evaporate, yielding crystals. To 50 mg of the 
crystals of each drug was added zinc dust 
(50 mg) and 5ml 1M hydrochloric acid in a 
beaker in a boiling water bath for 5 min.  The 
beaker was removed and then left to stand at 
room temperature for 20 min.  The resulting 
product was dissolved in 50ml acetone at 50 
o
C in a water bath and filtered hot. The filtrate 
was again allowed to stand for 10 min at 
room temperature to allow the solvent to 
evaporate, leaving crystals. An amount of the 
crystals (20 mg) was dissolved in 10 ml 
chloroform to form the test solution. Similarly, 
20mg of paracetamol powder was dissolved 





Nitric acid reaction: To 1ml of the test 
solution was added three drops of 2M nitric 
acid. One drop of sodium hydroxide (40 
%w/v)
 
was added after 2 min. 
 
Sodium nitrite reaction: 1 g of sodium nitrite 
and 1 ml of 2M sulphuric acid were mixed in 
a test tube and cooled in ice.  To 1 ml of the 
test solution was added one drop of the 
sodium nitrite reagent. 
 
Bismuth subnitrate reaction: Bismuth 
subnitrate (20 mg) was dissolved in 3 ml of 
2M hydrochloric acid. This was diluted with 
water to 10 ml, 10 g of potassium iodide was 
added. This reagent (2 ml) was added to 1 ml 




Thin layer identification (TLC) identification 
was carried out on a GF254 plate (5cm x 
10cm). Mobile phase A consisted of acetone, 
ethyl acetate and ammonia (100:5:1, v/v) 
while phase B consisted of acetone, 
chloroform and ammonia (100:15:1, v/v). 
Crystals obtained from the similarly treated 
drug products were dissolved in acetone to 
give a reference solution of 10 mg/ml. Two 
 
Table 1: Drugs evaluated 
 
Product code  
Product 
details MA MB TC TD S 
Generic  
name 
Metronidazole Metronidazole Tinidazole Tinidazole Secnidazole 












Manufacturer May & Baker Emzor May & 
Baker 
Cadila May &Baker 















Tablet Tablet Tablet Tablet Tablet 
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millitres each of the reference and test 
solutions were spotted on the plates. The 
plates were developed, allowed to dry in air 
for 3 min and placed in an iodine tank for 5 
min. TLC was performed in three laboratories 
in universities in Nigeria to accommodate 
possible variations in findings arising from 
differences in environmental conditions. The 
environmental conditions were 30 
o
C/45 
%RH (University of Uyo); 25 
o
C/65 %RH 
(University of Calabar); and 35 
o
C/27 %RH 
(University of Sokoto). Three chromatograms 
were run per brand of drug/sample in each 




The results of the colour reactions for the 
various product brands are outlined in Tables 
2 - 4 along with Rf values. The colours 
observed for the generic metronidazole, i.e., 
MA and MB, were similar for each of the 
reagent/test employed. Nitric acid test was 
not substituent-specific as orange colour was 
produced irrespective of the generic type of 
the nitroimidazole used. Sodium nitrite and 
bismuth subnitrate distinguished between 
metronidazole and the other two products as 
it gave a different colour.   
 














MA Orange Brown Brown 
MB Orange Brown Brown 
TC Orange Red Red 
TD Orange  Red  Red 
S Orange  Red Red 
 
M, T and S represent metronidazole, tinidazole and 
secnidazole, respectively, with A and B as brands of 






Concentrated nitric acid, when employed with 
concentrated sulphuric acid, is used to 
indicate the aromatic character of a 
substance. A yellow colour is usually 
produced when 10% w/v sodium hydroxide is 
added to a substance with aromatic 
character, turning orange with excess alkali. 
The aminoimidazole formed by the 
zinc/hydrochloric acid reaction during the 
preparation of the test solution was 
reconverted via oxidation to nitroimidazole by 
nitration.  Hence, reaction with concentrated 
nitric acid gave the expected result due to the 
aromatic nature of 5-nitroimidazoles, as the 
addition of 40 %w/v sodium hydroxide 
provided the excess alkali required to 
produce an orange colour which results from 
the formation of an aromatic nitro compound.  
 
Table 3:  Mean Rf values of various brands of 5-
nitroimidazole products evaluated in three 
laboratories, using mobile phase A (n=3). 
 
Lab, MA MB TC TD S 
1 0.460 0.470 0.750 0.730 0.520 
2 0.420 0.460 0.750 0.740 0.530 
3 0.460 0.470 0.770 0.760 0.540 
Mean 0.447 0.467 0.757 0.743 0.530 
S.D± 0.023 0.006 0.012 0.015 0.010 
 
M, T, S denote metronidazole, tinidazole and 
secnidazole, respectively, while 1, 2, 3 denote 
laboratories in University of Sokoto, University of Uyo 
and University of Calabar, respectively. 
 
Table 4:  Mean Rf values of the various rands 
of 5-nitroimidazole drugs in three aboratories, 
using mobile phase B (n=3) 
 
Lab. MA MB TC TD S 
1 0.680 0.680 0.540 0.550 0.700 
2 0.680 0.640 0.530 0.530 0.710 
3 0.680 0.650 0.520 0.530 0.720 
Mean 0.680 0.657 0.530 0.537 0.710 
S.D± 0.000 0.021 0.010 0.010 0.010 
 
M, T, S denote metronidazole, tinidazole and 
secnidazole, respectively, while 1, 2, 3 denote 
laboratories in University of Sokoto, University of Uyo 
and University of Calabar, respectively. 
 
All the brands of 5-nitroimidazole tested in 
our experiments gave an orange colour in the 
nitric acid test (Table 1). A drug that could be 
fraudulently labelled as an anti-infective is 
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paracetamol due to its low cost and mild anti-
pyretic effect [21]. It has been noted that 
some labelled anti-infectives only reduce 
symptoms of illnesses for a while. The colour 
observed was brown for metronidazole 
brands, MA and MB, in sodium nitrite and 
bismuth subnitrate tests. Concentrated 
sulphuric acid reduced the nitro compound to 
the amino derivative as the sodium nitrite 
subsequently formed a diazotization 
derivative with the observed colour based on 
the extent of conjugation. Sodium nitrite in 
acidic medium forms diazonium salts with 
compounds bearing free amino group. The 
alkyl substituent on the imidazolyl nitrogen 
distinguishes the 5-nitroimidazole by the 
characteristic colours observed in sodium 
nitrate and bismuth subnitrate tests. The alkyl 
substitution on metronidazole is ethyl alcohol 
(a primary alcohol) which confers a brown 
colouration on the compound while tinidazole 
which bears ethyl sulphone gives a red 
colouration with the reagents.  The N-
substitution on secnidazole is a secondary 
alcohol and this confers a red colour deeper 
in intensity than observed for tinidazole. The 
attached substituents on any system 
containing delocalized electrons either 
withdraw from the ring or donate electrons to 
it to a more or lesser extent. The colours, 
therefore, produced by such compounds 
depends on the availability and density of 
available electrons which affect the 
absorption and transmission of light.        
 
TLC Methods A and B 
 
The mobile phases A and B were designed to 
make a distinction between the 5-
nitromidazole compounds. In the TLC 
systems, metronidazole and secnidazole 
were differentiated from tinidazole by reason 
of their Rf  values. The Rf values of 
metronidazole brands,MA and MB in the 
various laboratories were similar. A similar 
finding was observed for the brands of 
tinidazole, TA and TB. The Rf values of the 
brands of tinidazole were higher than those of 
metronidazole and secnidazole in the solvent 
systems (seeTable 4). This is probably due to 
its ethylsulphone substitution as against the 
primary and secondary alcohol functional 
group affiliations of metronidazole and 
secnidazole, respectively. 
 
The spots produced with solvent system B 
were more conspicuous on exposure to 
iodine vapour in the tank. The movement of 
the solutes was also freer as indicated by Rf 
values. While the spots for the brands of 
metronidazole and secnidazole were distinct, 
the ones for tinidazole exhibited tailing and 
had a lower Rf (Table 4). 
  
Influence of some variables on the 
method  
 
The TLC experiments were conducted in 
laboratories situated in the three major 
geographic regions of Nigeria spanninging 25 
– 60 % relative humidity and a temperature 
range of 25 – 35 
o
C. These tests were 
performed in different regions in order to 
determine if differences in temperature and 
humidity across the country would influence 
the tests. Although Rf values were not highly 
reproducible, the relative pattern of 
appearance of the spots in the 
chromatograms was constant and, therefore, 




An identification system for the detection and 
screening of 5-nitroimidazole preparation was 
established by combining both the colour 
reaction and TLC tests. The identification 
system was rapid (Fig 2) and thus suitable for 
screening the 5 – nitroimidazole  drugs tested 
in this work. However, since fraudulent 
labelling and other substandard features 
(e.g., excess or shortfall in the content of 
active ingredient in the formulation) often 
characterise unacceptable products, this 
identification system does not in any way 
obviate the need for quantitative evaluation of 
this group of drugs.  
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The developed identification system based 
on colours produced by chemical interaction 
of reagents with the functional groups present 
in the molecule of 5 – nitroimidazole  drugs, 
and TLC methods can be jointly used to 
identify fake drugs that are fraudulently 
labelled as 5-nitroimidazole. This 
identification system should be useful to 
those involved in drug distribution, especially 
community pharmacies and pharmacy 
departments of hospitals since it will afford 
them a qualitative assessment of the 
products. It should, however, be emphasized 
that the tests evaluated do not eliminate the 
need for quantitative assessment of this 
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